Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
R
Ryvu Therapeutics SA
WSE:RVU
Ryvu Therapeutics SA
WSE:RVU
Price:
15.9
PLN
-1.12%
Market Cap:
zł367.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
PL |
Wall St Price Targets
RVU Price Forecast
Based on 4 analysts
Based on 4 analysts
+73% Upside
from
zł15.9
today
Ryvu Therapeutics SA (RVU)’s 12-month stock price forecast through September 2027 has a consensus target of zł27.54, implying 73% upside. The forecast is based on price targets from 4 Wall Street analysts.
Ryvu Therapeutics SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RVU's stock price target?
Price Target
27.54
PLN
27.54
PLN
According to Wall Street analysts, the average 1-year price target for RVU is 27.54 PLN with a low forecast of 17.17 PLN and a high forecast of 30.45 PLN.
What is the Revenue forecast for Ryvu Therapeutics SA?
Projected CAGR
22%
22%
Over the last 12 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 22%.
What is the Gross Profit forecast for Ryvu Therapeutics SA?
Projected CAGR
40%
40%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next -3 years is 40%.